Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

Condition(s) studied

Investigational drug(s) / intervention(s)

Chest and abdominal compression: Abdominal compression suppresses respiratory movement in patients

breathing management: Apply pressure to the patient's abdomen to achieve respiratory movement inhibition

Study summary

The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is:

Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors?

Participants will:

Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement

Eligibility

Primary outcome measure(s)

• Tumor displacement range — Within 6 months after enrollment
  Based on 4DCT for delineating tumor motion range and extracting radiomics features in patients with and without respiratory management

Trial sites (1)

More Tianjin Medical University Cancer Institute and Hospital trials in China

Other trials for the same condition